December 10, 2015: Markets opened lower for a fourth consecutive day on Thursday but almost immediately broke into positive territory and remained there for most of the day. Every sector traded higher…
The November 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was up.
December 3, 2015: Markets opened slightly higher on Thursday but any inference that equities were in for a good day were soon crushed as stocks turned south and have traded lower for…
December 1, 2015: Markets opened higher on again on Tuesday and, unlike yesterday, held on to the gains for the most of the day. Equities took their cue from markets in Asia…
November 30, 2015: Markets opened higher on Monday but the upbeat start to the day didn’t last long. Industrials and consumer discretionary stocks weighed most heavily on equity indexes today, with energy…
November 27, 2015: Markets opened mixed on Friday but only narrowly up or down from Wednesday’s close. No economic data was due out today and there was little corporate news as well.…
Despite the howling from political candidates trying to make the top drug-makers their whipping boy in populist campaign efforts, the need and demand for pharmaceuticals will only continue. This is especially the case…
Tuesday's top analyst upgrades, downgrades and initiations include Antero Resources, Athenahealth, Capstone Turbine, Clovis Oncology, Genworth Financial, Merck, Nuance Communications and Salesforce.com.
Merck is joining the likes of Gilead Sciences in producing hepatitis C vaccines, but it is still in the early clinical stages.
November 11, 2015: Markets opened up on Wednesday but over the course of the day the markets drifted lower to close the day marginally negative. The dollar gained only slightly while equities…
The short interest data have been released for the October 30 settlement date, and for most of the selected pharmaceutical stocks, short interest was down.
ThinkstockOctober 28, 2015: Markets opened higher on Wednesday and bounced of intra-day lows following the FOMC announcement which led investors to believe that interest rates may rise in December. Energy markets were…
Pfizer and Merck both released their third-quarter earnings on Tuesday morning. So, which drug giant is looking better after earnings?
The October 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was mixed.
Merckis expected to report its third-quarter financial results before the markets open on Tuesday.
Chris Lange 
